News
Scottish scientists develop world-first ‘micro-placenta’
Scientists say the breakthrough technology could revolutionise research into conditions such as preeclampsia

A new micro-placenta model grown from stem cells could “revolutionise” research into pregnancy complications, Scottish scientists have said.
iPlacenta, developed by experts at Dundee’s School of Medicine, allows researchers to examine the workings of the organ in 3D for the first time without risk to a mother or her foetus.
The culmination of four years of research and £3.9m of funding, the miniature models have been developed from stem cells, perfectly replicating the organ’s workings.
The placenta is one of the least studied organs in medical science. It allows nutrients to pass from the mother to the foetus while allowing waste to return to the mother’s bloodstream. It also offers protection to the unborn baby against bacteria, though viruses can still be transmitted.
However, a failure by the placenta to function correctly can jeopardise the health and life of both foetus and its mother, with the British Heart Foundation stating that conditions such as preeclampsia affect as many as one in 25 UK pregnancies.
Despite this prevalence, little is known about the workings of the placenta and aspirin and early deliveries are among the limited treatments offered to mothers.
To address this urgent need, Dr Colin Murdoch and his team at Dundee started work on iPlacenta in 2019, working with Dutch 3D tissue model experts MIMETAS, utilising stem cells obtained from skin to grow human placentas in their organ-on-a-chip platform, OrganoPlate.
Each plate can hold around 40 micro placentas, which mimic the workings of the full-size organ and can be used for testing without jeopardising the health of the mother or foetus, or without resorting to animal testing.
Dr Murdoch, who has led the project, said that the breakthrough technology could revolutionise research into conditions such as preeclampsia.
“Just a tiny fraction of the most common drugs used by women in pregnancy have excellent safety data behind them,” he said.
“However, iPlacenta can be utilised by the pharmaceutical industry to research the interaction between drugs and the placenta. This allows drug companies to look at the organ in a more physiological format and could have a potentially transformative impact on medical care for pregnant women.”
Research in pregnancy is not as far forward as research into other areas of medical science, Murdoch explained.
“We still know relatively little about preeclampsia, despite its potential to affect every pregnancy.
“At present, cell lines from cancer are used to examine diseases of the placenta but this is not entirely appropriate. Obtaining placentas at the early stage that we need to study them is incredibly hard, and that is where iPlacenta can address that need.”
Gwenaëlle Rabussier, scientist at MIMETAS, said: “Organ-on-a-chip technology is a giant leap forward in understanding the diseases of the placenta.
“Organs are three-dimensional objects, but until now medical research has been conducted in just two dimensions.
“Working on this project has been exciting as it opens tremendous opportunities for unravelling placental mysteries associated with placental barrier drug transfer and pathologies such as preeclampsia. This contribution to enhancing women’s health is a tremendous source of pride for us.”
iPlacenta was funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement.
The findings of the iPlacenta project were detailed in a paper published in the journal Cell Press.
News
What “women’s healthmaxxing” means for patient trust and the femtech industry

Women’s health has become one of the most searched and shared topics online, from cycle syncing and cortisol management to menopause hacks, supplements, hormone testing and clinician-creator content.
That surge in attention, sometimes dubbed “healthmaxxing,” is changing how women find, evaluate and act on health information, and it is starting to reshape the relationship between patients, clinicians and the companies building products for this market.
For providers, the shift means patients are arriving better informed but also more exposed to unverified claims, putting pressure on clinicians to engage with online narratives rather than dismiss them.
For femtech and pharma companies, it opens a route to reach and educate consumers at scale, but also raises the stakes on credibility: products and messaging that ride the trend without clinical grounding risk eroding the trust the industry has spent years building.
Investors are watching the same dynamic from a different angle.
Attention-driven demand can be a signal of where the next wave of femtech growth will come from, but distinguishing genuine clinical need from viral momentum is increasingly part of due diligence.
The net effect is a widening gap between companies that treat cultural attention as a distribution channel for credible, evidence-based care, and those that risk being swept up in trends with little clinical substance behind them.
How that gap plays out will shape patient trust, clinical relationships and commercial opportunity across the women’s health industry for years to come.
These themes will be explored in more depth in an upcoming webinar, “Women’s Healthmaxxing: The Opportunity & Risks of Cultural Attention for the Women’s Health Industry,” hosted by the Women’s Health Innovation Summit (WHIS), featuring Ellen Wilcox (Listen Ventures), Jessica Bell van der Wal (Frame Fertility), Dr. Tosin Sotubo-Ajayi (NHS, BBC and more) and Nora Lansen (Elektra Health).
Register free for the webinar on 23 July 2026 at https://events.virtualpro.com/womens-health-series-webinar-july-2026/registration
Insight
Rising number of young midwives quitting NHS due to burnout

More young midwives are leaving the NHS before 35 as burnout adds pressure to stretched maternity services, new research has revealed.
The trend has raised concerns about the quality and safety of care for mothers and babies in understaffed maternity units.
During 2025-26, 1,669 midwives aged 34 or under left the health service in England, representing 57 per cent of the 2,949 midwives of all ages who resigned.
The pressures of maternity care, including increasingly complex childbirth and the risks involved, are thought to be among the factors behind the trend.
Hannah Leonard, deputy chief midwife at the Royal College of Midwives, said the exodus of midwives under 35 was “deeply worrying” and showed that too many were ending up “burnt-out within a few years of qualifying because every shift means too few colleagues, missed breaks and unpaid hours”.
She added: “Losing these midwives, and students, even before they qualify, is a terrible waste of talent.”
The figures, revealed in parliamentary questions tabled by the Liberal Democrats, show that 205 of last year’s younger leavers were under 25, while 655 were aged 25 to 29 and 809 were aged 30 to 34.
The number of midwives under 35 leaving the NHS has risen sharply in recent years. The 2025-26 figure was 59 per cent higher than the 1,051 who left in 2014-15, according to NHS figures.
Burnout means long-term physical and emotional exhaustion, often linked to sustained pressure at work.
Separate figures obtained by the Liberal Democrats suggest almost one in four midwifery students are leaving before completing their three-year degree.
In 2021, 3,565 students started a midwifery degree, but 2,725 graduated in 2024, meaning 840, or 24 per cent, did not complete the course.
Midwifery students spend much of their second and third years learning on the job in maternity units.
The loss of staff and students underlines what the Royal College of Midwives has described as a “staffing emergency” in maternity care across the UK.
A recent survey by the Royal College of Midwives found that three-quarters of midwives had considered leaving the profession over the last year, mainly because of concerns over staffing levels and patient safety.
Both recent large-scale reviews of maternity care in England, led by Donna Ockenden and Valerie Amos, identified staffing shortages as a key problem affecting patient safety.
Helen Morgan, the Liberal Democrat health spokesperson, said: “These statistics reveal an alarming crisis in maternity, with far too many midwives burning out early in their career and in their training. Patients are paying the price, and mothers are left with no alternative but to give birth on understaffed and unsafe wards.
“Rather than throw money at yet more new recruits who quit under intolerable pressure, the government needs a new approach. Through guaranteeing protected, year-round training and professional development we can help midwives cope with rising complexity and risk.”
About 10 per cent of all midwives leave the NHS each year.
However, the figures show higher leaving rates among younger midwives, with one in seven, or 14.6 per cent, of those aged 25 to 29 and one in six, or 16.6 per cent, of those aged 30 to 34 leaving during 2025-26.
A Department of Health and Social Care spokesperson said: “Under this government we have a record number of midwives in the workforce and we value the vital service they provide in maternity and neonatal units across the country.
“To make the NHS the best employer it can be, we have introduced new NHS staff standards to improve health and wellbeing support, promote flexible working, as well as crucial measures to tackle violence, sexual harassment or abuse and racism.
“Alongside consecutive above-inflation pay rises, we’ve bolstered the midwifery workforce through our graduate guarantee and recently opened up 1,000 more midwifery roles backed by £10m to help prevent student midwives leaving the profession.”
Department of Health and Social Care figures show a record 25,500 full-time-equivalent midwives are working in the NHS, 2,000 more than when the Labour government took office in July 2024.
Mental health
Nearly 60% of young women get health advice from influencers, research finds

Nearly six in ten young women get health and wellness advice from influencers, new research shows.
Women aged 18 to 29 were more likely than young men to use online influencers for health information.
The topics included beauty, alternative medicine, mental health, weight loss and fitness.
The Pew Research study found that 57 per cent of women aged 18 to 29 said they get health and wellness information from online influencers, 10 percentage points higher than young men.
While Americans still mostly rely on healthcare providers, the research suggests social media influencers also play a major role in how young people find health advice.
Among women who get health and wellness information from influencers, 51 per cent said they often hear about beauty and appearance, compared with 18 per cent of men.
Young women were also around twice as likely as young men to say they see content about alternative medicine, meaning treatments or health practices used outside mainstream medical care.
A third or more of both young men and young women said they often hear about mental health and weight loss from influencers.
Around half or more of both groups said they often see fitness content.
When asked why they seek health and wellness information from influencers, around half of young women said they wanted to make a change to their health or lifestyle.
That compared with 37 per cent of young men.
The research also found that 23 per cent of young women said hearing from people who share their background or beliefs was one reason they used influencers, compared with 14 per cent of young men.
A further 19 per cent of young women said they learnt about things they did not want to ask their doctor, compared with 10 per cent of young men.
Diagnosis2 weeks agoTwo “gamechanger” tests set to speed up endometriosis diagnosis on the NHS
Insight2 weeks agoWomen with PMOS should have annual NHS checks, new guidance says
News6 days agoNew menopause drug approved for use by NHS in Scotland
Cancer2 weeks agoThousands of women could avoid painful cancer exam with new AI blood test
Entrepreneur2 weeks agoApplications open for the third W Accelerate with Merck KGaA and M Ventures
Fertility2 weeks agoOlder women face lower chance of fertility treatment working, even with donor eggs, study finds
News2 weeks agoWe built Ema like a nurse: Here’s why that matters
News2 weeks agoExperts call for regulation of toxic period product chemicals







10 Comments